The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPowerhouse Ener Regulatory News (PHE)

Share Price Information for Powerhouse Ener (PHE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.975
Bid: 0.95
Ask: 1.00
Change: 0.00 (0.00%)
Spread: 0.05 (5.263%)
Open: 0.975
High: 0.975
Low: 0.975
Prev. Close: 0.975
PHE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of entire shareholding of Engsolve Ltd

22 Jun 2023 07:00

RNS Number : 4967D
Powerhouse Energy Group PLC
22 June 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.

 

22 June 2023

 

Powerhouse Energy Group Plc

 (the "Company" or "PHE")

 

Acquisition by PHE of the entire shareholding of Engsolve Ltd

 

Powerhouse Energy Group Plc (AIM: PHE), a company pioneering integrated technology that converts non-recyclable waste into low carbon energy, is pleased to announce that it has completed the acquisition of the entire outstanding shareholding of the engineering consultancy company, Engsolve Ltd ("Engsolve") for a cash consideration of £572,000.

 

Reason for the acquisition

On 12 August 2021, PHE announced that it had acquired a 48% stake in Engsolve, a private company based in Bridgend that has worked closely with PHE on the Protos Plastics to Hydrogen project and more recent prospective projects. Engsolve has significant experience in engineering design and support, cost estimating and control, project management and safety risk assessments across a range of industries including energy from waste, renewables and green energy, and will complement PHE's capabilities in the development of its technology and project implementation. The inhouse engineering capability will also permit PHE to develop revenue streams into the Company that previously were not available to it. For the year ended 31 March 2022 Engsolve recorded a profit for the year of £195,155.

 

Related party transaction

Engsolve was owned 48% by PHE and 52% by its two directors, Paul Emmitt and Richard Riddell. Mr Emmitt is the Chief Operating Officer of PHE. Mr Emmitt has sold his entire holding in Engsolve and is a related party under the AIM Rules for Companies. The transaction with him is therefore a related party transaction under these regulations.

 

The independent Directors of the Company (being the full board except for Paul Emmitt and Keith Riley who are deemed to be not independent due to their roles as directors of Engsolve), having consulted with WH Ireland, PHE's Nominated Adviser, consider the terms of the related party transaction to be fair and reasonable insofar as shareholders of the Company are concerned.

 

Tony Garner-Hillman, Non-Executive Chairman of PHE commented:

"We are delighted to have acquired the remaining share capital of Engsolve. This Acquisition consolidates Engsolve's position within PHE and will provide the Company with a secure engineering resource that will enhance the Company's capabilities and business for the future."

 

 

Paul Emmitt, Managing Director and Founder of Engsolve commented:

"I welcome PHE completing the acquisition of Engsolve and look forward to growing the PHE business in the acceleration of the clean energy transition that is so urgently needed. The acquisition is testament to the expertise of the Engsolve team, and of their efforts since Incorporation, I believe this will lead to growth and provide much needed resource for PHE."

 

Keith Riley, Acting CEO of PHE commented:

"I have been working closely with Paul and the Engsolve team since I joined PHE. They are a very capable and motivated group of people. Having them totally committed to the PHE business will be a real boon for the Company. I also see the integration of Engsolve into PHE as being critical for the Company as it will give us a base on which to grow the engineering services arm of the company as well as strengthening the engineering support of our capital-intensive projects. This is the start of a new era for PHE."

 

 

For more information, contact:

 

Powerhouse Energy Group plc

Keith Riley

 

 

powerhouse@tavistock.co.uk

 

WH Ireland Limited (Nominated Adviser)

James Joyce

James Bavister

Enzo Aliaj

 

 

+44 (0) 207 220 1666

Turner Pope Investments (TPI) Ltd (Joint Broker)

Andrew Thacker

James Pope

 

 

+44 (0) 203 657 0050

Tavistock (Financial PR)

Simon Hudson

Nick Elwes

Heather Armstrong

powerhouse@tavistock.co.uk

 

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

 

 

About Powerhouse Energy Group plc

PHE has developed a process technology which can utilise waste plastic, end-of-life-tyres, and other waste streams to convert them efficiently and economically into syngas from which valuable products such as chemical precursors, hydrogen, electricity, heat and other industrial products may be derived.

 

PHE's process produces low levels of safe residues and requires a small operating footprint, making it suitable for deployment at enterprise and community level.

 

PHEs quoted on the London Stock Exchange's AIM Market under the ticker: PHE and is incorporated in England and Wales.

 

For more information see www.powerhouseenergy.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQFBMATMTATBIJ
Date   Source Headline
16th Apr 20247:00 amRNSTechnical Centre Update
18th Mar 20247:00 amRNSSubsidiary Contract
11th Mar 20247:00 amRNSUpdate on Longford Project JV
22nd Feb 20247:00 amRNSFramework Agreement with National Hydrogen
19th Feb 202412:32 pmRNSCorporate Activity Update
6th Feb 20245:20 pmRNSUpdate on European Patent Claim
31st Jan 20247:00 amRNSAppointment of Nominated & Financial Adviser
12th Dec 20237:00 amRNSDirector’s Dealing
11th Dec 20237:00 amRNSDirector’s Dealing
8th Dec 20237:00 amRNSDirectorate Update
27th Nov 20237:00 amRNSDirectorate Update
15th Nov 20237:00 amRNSDirectorate Change
6th Nov 20237:00 amRNSEuropean Patent update
30th Oct 20237:00 amRNSDeferral of Commitment to JV with HUI
6th Oct 20232:16 pmRNSPowerhouse Technology Centre Project Update
15th Sep 20237:00 amRNSEuropean Patent Grant Confirmed
7th Sep 20234:05 pmRNSResult of AGM
6th Sep 20237:05 amRNSHalf Year Report
6th Sep 20237:00 amRNSChange of directorate
22nd Aug 20237:00 amRNSPlacing to raise £1,000,000 and issue of equity
16th Aug 20237:00 amRNSNotice of AGM
13th Jul 20237:00 amRNSEuropean Patent Application Allowed
30th Jun 20237:00 amRNSAudited Results for Year Ended 31 December 2022
22nd Jun 20237:00 amRNSAcquisition of entire shareholding of Engsolve Ltd
30th May 20237:00 amRNSAppointment of representative in Northern Ireland
2nd May 20237:00 amRNSAcquisition of the entire shareholding of Protos
3rd Apr 20237:00 amRNSExtension of agreements with Peel
31st Mar 20237:00 amRNSPHE discussions with National Hydrogen Australia
21st Mar 20237:00 amRNSJoint Venture with HUI Plc
16th Mar 20239:00 amRNSCompletion of lease on Technology Centre
27th Feb 20237:00 amRNSHolding(s) in Company
27th Feb 20237:00 amRNSHolding(s) in Company
27th Feb 20237:00 amRNSHolding(s) in Company
22nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
22nd Feb 202311:05 amRNSSecond Price Monitoring Extn
22nd Feb 202311:00 amRNSPrice Monitoring Extension
22nd Feb 20237:00 amRNSFramework Services agreement with Petrofac
16th Feb 202311:05 amRNSDirectorate Change
23rd Jan 202312:27 pmRNSUpdate on Konin facility, Poland
12th Jan 202311:05 amRNSSecond Price Monitoring Extn
12th Jan 202311:00 amRNSPrice Monitoring Extension
11th Jan 20234:40 pmRNSSecond Price Monitoring Extn
11th Jan 20234:35 pmRNSPrice Monitoring Extension
4th Jan 20234:40 pmRNSSecond Price Monitoring Extn
4th Jan 20234:35 pmRNSPrice Monitoring Extension
30th Dec 20227:00 amRNSDirectorate Changes and Operational Update
19th Dec 20222:05 pmRNSSecond Price Monitoring Extn
19th Dec 20222:00 pmRNSPrice Monitoring Extension
19th Dec 202211:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.